AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
7min chapter
Novo Nordisk (Ozempic)
Acquired
The Race for Human Insulin
This chapter explores the race between Genentech, Novo Nordisk, and Eli Lilly to produce and market human insulin. It discusses the development of recombinant DNA technology and its significance in replacing animal insulin with human insulin. The chapter also highlights the strategies and challenges faced by Novo Nordisk as they race to market with modified pig insulin.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode